AGING CELL is a premier peer-reviewed journal published by Wiley, specializing in the rapidly evolving field of aging research and cell biology. Established in 2002 and enjoying an impressive track record as evidenced by its Q1 ranking in both Aging and Cell Biology categories for 2023, the journal has become a vital resource for researchers and professionals alike. With a significant impact factor highlighting its scholarly influence, AGING CELL offers an open access model since 2014, ensuring that groundbreaking research is accessible to the global community. The journal covers a wide array of topics related to the mechanisms of aging at the cellular and molecular levels, making it essential reading for anyone invested in understanding the complexities of aging processes and their implications for health and disease. With a broad international readership based in the United Kingdom and beyond, AGING CELL is dedicated to disseminating high-quality research that impacts scientific understanding and fosters advances in the field.

Aging and Disease is a leading open-access journal published by the International Society on Aging and Disease, dedicated to advancing the understanding of aging and its associated diseases. Since its inception in 2010, the journal has established itself as a vital resource for researchers and practitioners in the fields of Geriatrics, Neurology, Cell Biology, and Pathology. With an impressive Q1 ranking across multiple categories and a robust position in Scopus rankings, including ranks in the top 3% in Geriatrics and Gerontology, it showcases high-quality research that addresses the complexities of aging processes. Each issue presents original articles, reviews, and insights aimed at improving health outcomes for the aging population. The open-access model ensures that valuable research findings are readily available to a global audience, fostering collaboration and innovation. As a go-to publication for scholars, healthcare professionals, and students, Aging and Disease significantly contributes to the multidisciplinary dialogue surrounding aging and its health implications.

GeroScience, published by Springer, is an esteemed open-access journal that focuses on the multidisciplinary field of aging research. Since its inception in 2017, the journal has quickly established itself as a leader in its field, achieving impressive Q1 quartile rankings across various categories, including Aging, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, and Complementary and Alternative Medicine, as per 2023 evaluations. With a significant impact factor that underscores its influence and reach in academia, GeroScience aims to disseminate high-quality research that addresses the complex challenges and advancements related to aging. Its accessible publication format fosters greater dissemination of knowledge and encourages collaboration among researchers, practitioners, and students eager to contribute to the growing body of work on age-related health issues. As it continues to thrive, GeroScience remains a pivotal resource for anyone looking to stay at the forefront of aging research.

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.

EXPERIMENTAL GERONTOLOGY is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the evolving field of aging research. With a rich history dating back to 1964 and continuing through 2024, this journal aims to advance the understanding of the biological processes underlying aging and develop interdisciplinary approaches to improve healthspan. ENCOMPASSING a broad scope, including *biochemistry*, *cell biology*, *endocrinology*, *genetics*, and *molecular biology*, it holds impressive rankings in the 2023 Scopus Ranks, featuring in Q1 and Q2 quartiles across multiple categories. This positions it as a vital resource for researchers and professionals focused on gerontology and related fields. As a subscription-based journal without open access, EXPERIMENTAL GERONTOLOGY ensures the dissemination of high-quality research through rigorous peer review, making it an essential publication for those aspiring to remain at the forefront of aging studies.

The Lancet Healthy Longevity is a premier journal published by Elsevier that focuses on advancing our understanding of healthy aging and longevity through interdisciplinary research. Established in 2020, this Open Access journal is committed to disseminating innovative findings that enhance public and individual health, making it accessible to a global audience. The journal is proud to be recognized with a Q1 ranking in critical categories such as Family Practice, Geriatrics and Gerontology, Health (Social Science), and Psychiatry and Mental Health, indicating its prominent role in shaping contemporary discourse in these domains. As one of the leading titles within the field, it holds an influential position in Scopus rankings, with top placements in Geriatrics and Gerontology as well as Family Practice, thereby reaching the 99th percentile of scholarly impact. The Lancet Healthy Longevity aims to foster collaboration among researchers, healthcare professionals, and policymakers to promote healthy longevity, ultimately supporting the growing aging population worldwide. With its commitment to high-quality research and global accessibility, this journal is a vital resource for those dedicated to improving health outcomes across the lifespan.

Clinical Interventions in Aging is a premier Open Access journal published by DOVE MEDICAL PRESS LTD that has been at the forefront of geriatric research since its inception in 2006. With its core focus on innovative interventions and evidence-based practices to enhance the quality of life for the elderly, this journal serves as a vital resource for researchers, healthcare professionals, and students in the fields of geriatrics and gerontology. The journal boasts a commendable impact factor, achieving a Q2 ranking in Geriatrics and Gerontology and a Q1 ranking in Medicine (miscellaneous) as of 2023, highlighting its significant academic contribution. Notably, its Scopus ranking places it in the top 31% of its category, underscoring the relevance and quality of the research it publishes. With a commitment to advancing knowledge, this journal not only promotes accessibility through its Open Access model but also ensures that cutting-edge studies are readily available to those dedicated to improving geriatric care. Located in Auckland, New Zealand, the journal continues to expand its influence globally, making it an essential platform for discussions surrounding aging and health.

FREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.

Journals of Gerontology Series A: Biological Sciences and Medical Sciences, published by Oxford University Press Inc, stands at the forefront of aging research, bridging the gap between biological sciences and medical practices to address the complexities of gerontology. With an impressive impact factor reflecting its significant contribution to the field, this journal is recognized within the Q2 quartile in Aging and the Q1 quartile in Geriatrics and Gerontology for 2023, evidencing its high-quality scholarship and relevance. Researchers and professionals will find valuable insights through its comprehensive coverage of aging-related topics, informed by cutting-edge studies ranked among the top in their category—Rank #11 in Geriatrics and Gerontology and Rank #9 in Aging on Scopus. The journal aims to disseminate innovative research that can impact health care practices and enhance the quality of life in older populations. For those engaged in studies of aging, this journal offers a vital platform for sharing knowledge and advancing the understanding of biological and medical sciences as they pertain to gerontology.

Aging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.